BioStock: Elicera gives an update in Cancer Immunotherapy Month

June is recognised globally as Cancer Immunotherapy Month, with the aim of shedding light on the role of immunotherapy in cancer. This type of treatment has revolutionised the field of oncology by extending the survival of cancer patients suffering from some of the deadliest cancers. In connection with Cancer Immunotherapy Month, BioStock contacted Elicera Therapeutics, a biotechnology company active in the field.

Read the interview with Elicera Therapeutics at biostock.se:

https://www.biostock.se/en/2023/06/elicera-gives-an-update-in-cancer-immunotherapy-month/

This is a press release from BioStock - Connecting Innovation and Capital. https://www.biostock.se/en/